Tripoor Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth -144.69%
- Ebitda -76.14%
- Net Worth -8.94%
- Total Assets -10.15%
About Tripoor Sciences
Tripoor Sciences Private Limited (TSPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 December 2020 (Four years and one month 8 days old ). Its registered office is in Surat, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Anandkumar Tulsian, Ekta Tulsian, Jhanvi Tulsian, and One other member serve as directors at the Company.
Company Details
-
Location
Surat, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24290GJ2020PTC119034
-
Company No.
119034
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Dec 2020
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Tripoor Sciences?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jhanvi Tulsian
|
Director | 23-Dec-2020 | Current |
|
Anandkumar Tulsian
|
Director | 23-Dec-2020 | Current |
|
Ekta Tulsian
|
Director | 23-Dec-2020 | Current |
|
Aadhay Tulsian
|
Director | 19-Apr-2021 | Current |
Financial Performance of Tripoor Sciences.
Tripoor Sciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 144.69% decrease in profit. The company's net worth dipped by a decrease of 8.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tripoor Sciences?
Unlock access to Tripoor Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tripoor Sciences?
Tripoor Sciences has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tripoor Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tripoor Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.